Total Payments
$6,982
2024 Payments
$300.55
Companies
39
Transactions
366
Medicare Patients
7,094
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$6,944 (99.5%)
Education$37.71 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,944 | 362 | 99.5% |
| Education | $37.71 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,101 | 92 | $0 (2024) |
| Novo Nordisk Inc | $1,085 | 63 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $605.40 | 37 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $533.00 | 18 | $0 (2023) |
| Lilly USA, LLC | $289.26 | 17 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $257.30 | 16 | $0 (2022) |
| PFIZER INC. | $225.92 | 14 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $148.18 | 8 | $0 (2021) |
| GlaxoSmithKline, LLC. | $145.95 | 9 | $0 (2023) |
| Amarin Pharma Inc. | $140.62 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $300.55 | 7 | AstraZeneca Pharmaceuticals LP ($267.27) |
| 2023 | $238.12 | 13 | Bayer Healthcare Pharmaceuticals Inc. ($77.88) |
| 2022 | $861.81 | 36 | Bayer HealthCare Pharmaceuticals Inc. ($455.12) |
| 2021 | $851.65 | 47 | AstraZeneca Pharmaceuticals LP ($224.85) |
| 2020 | $1,134 | 60 | AstraZeneca Pharmaceuticals LP ($320.81) |
| 2019 | $881.87 | 54 | AstraZeneca Pharmaceuticals LP ($260.51) |
| 2018 | $1,397 | 69 | AstraZeneca Pharmaceuticals LP ($565.32) |
| 2017 | $1,317 | 80 | AstraZeneca Pharmaceuticals LP ($296.21) |
All Payment Transactions
366 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Gastroenterology | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $112.00 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $111.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Gastroenterology | ||||||
| 09/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardio-renal | ||||||
| 08/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Cardio-renal | ||||||
| 07/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Gastroenterology | ||||||
| 07/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Respiratory | ||||||
| 05/03/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Gastroenterology | ||||||
| 03/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Cardio-renal | ||||||
| 02/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Diabetes | ||||||
| 01/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardio-renal | ||||||
| 12/19/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Cardio-renal | ||||||
| 11/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: Cardio-renal | ||||||
| 10/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardio-renal | ||||||
| 10/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: Cardio-renal | ||||||
| 09/16/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,281 | 3,281 | $460,790 | $246,318 |
| 2022 | 21 | 1,753 | 4,481 | $519,805 | $251,422 |
| 2021 | 26 | 1,956 | 5,546 | $574,814 | $274,676 |
| 2020 | 26 | 2,104 | 6,229 | $591,421 | $244,624 |
Total Patients
7,094
Total Services
19,537
Medicare Billing
$1.0M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 319 | 949 | $162,626 | $86,333 | 53.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 56 | 845 | $91,919 | $51,445 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 513 | $60,290 | $34,816 | 57.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 191 | 191 | $47,594 | $25,510 | 53.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 235 | $27,140 | $15,435 | 56.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 65 | 96 | $20,965 | $10,134 | 48.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $12,862 | $5,878 | 45.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 52 | 77 | $8,907 | $5,132 | 57.6% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 39 | 41 | $8,448 | $4,554 | 53.9% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 53 | 53 | $7,155 | $1,775 | 24.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 54 | $3,645 | $1,704 | 46.8% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 39 | 46 | $3,522 | $1,574 | 44.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 88 | 100 | $2,741 | $1,078 | 39.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,406 | $911.65 | 37.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 18 | $570.00 | $37.40 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 323 | 934 | $159,248 | $81,873 | 51.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 78 | 954 | $104,259 | $53,196 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 579 | $67,655 | $38,588 | 57.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 198 | 198 | $49,441 | $26,275 | 53.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 51 | 241 | $28,189 | $14,008 | 49.7% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 63 | 71 | $14,517 | $7,358 | 50.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 51 | 66 | $14,474 | $7,257 | 50.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $11,724 | $5,603 | 47.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 42 | 54 | $6,244 | $3,121 | 50.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 74 | 74 | $4,958 | $2,198 | 44.3% |
About Dr. Moises Siperstein-Blumovicz, M.D
Dr. Moises Siperstein-Blumovicz, M.D is a Internal Medicine healthcare provider based in Port Saint Lucie, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568436103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Moises Siperstein-Blumovicz, M.D has received a total of $6,982 in payments from pharmaceutical and medical device companies, with $300.55 received in 2024. These payments were reported across 366 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,944).
As a Medicare-enrolled provider, Siperstein-Blumovicz has provided services to 7,094 Medicare beneficiaries, totaling 19,537 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Port Saint Lucie, FL
- Active Since 02/13/2006
- Last Updated 03/23/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568436103
Products in Payments
- FARXIGA (Drug) $752.77
- Kerendia (Drug) $533.00
- SYMBICORT (Drug) $482.04
- INVOKANA (Drug) $358.89
- Ozempic (Drug) $356.06
- Victoza (Drug) $338.52
- BREZTRI (Drug) $334.45
- Tresiba (Drug) $291.15
- XARELTO (Drug) $246.51
- TOUJEO (Drug) $149.66
- BEVESPI AEROSPHERE (Drug) $149.16
- BREZTRI AEROSPHERE (Drug) $148.71
- Vascepa (Drug) $140.62
- TRELEGY ELLIPTA (Drug) $112.69
- NURTEC ODT (Drug) $104.55
- Uloric (Drug) $104.17
- XIFAXAN (Drug) $98.61
- TRULICITY (Drug) $94.23
- CHANTIX (Drug) $92.81
- BYDUREON (Drug) $86.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Port Saint Lucie
Dr. Agustin Sanz, Md, MD
Internal Medicine — Payments: $10,817
Internal Medicine $10,817
Richard Pena -Ariet, Md, MD
Internal Medicine — Payments: $8,827
Internal Medicine $8,827
Yohanna Deno, Md, MD
Internal Medicine — Payments: $5,956
Internal Medicine $5,956
Dr. Allan Birnbaum, D.o, D.O
Internal Medicine — Payments: $3,279
Internal Medicine $3,279
Michael Blum, D.o, D.O
Internal Medicine — Payments: $1,519
Internal Medicine $1,519
Dr. Sreenivasa Alla, M.d, M.D
Internal Medicine — Payments: $533.22
Internal Medicine $533.22